Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel, Active Drug Controlled, Double Blind, Randomized, Multi-center, Phase III Clinical Trial to Compare the Efficacy and Safety of MT10107 Versus BOTOX® in Treatment of Glabella Line

NCT03908008 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.

NCT NCT03908008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03908008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel, Active Drug Controlled, Double Blind, Randomized, Multi-center, Phase III Clinical Trial to Compare the Efficacy and Safety of MT10107 Versus BOTOX® in Treatment of Glabella Line
Lead sponsor
Medy-Tox
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
September 30, 2014
Enrollment
136 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar frown lines